Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorSpaulding Rehabilitation Hospital

About this trial

The study aims at evaluating physiological and patient-reported outcomes for a dual intervention approach including a stimulation device and support therapy in patients with functional dyspepsia.

Eligibility criteria

Qualifiers

Ability to give written consent and participate in behavioral intervention in English

Willingness to attend weekly treatment sessions over live video, daily self-administered transcutaneous auricular vagus nerve stimulation (taVNS) sessions, and engage in homework during treatment

Avoidance of alcohol, nicotine, and caffeine for 24 hours prior to study session

Diagnosis according to the Rome IV criteria for both epigastric pain syndrome and postprandial distress syndrome subtypes

Disqualifiers

Previous receipt of cognitive behavioral therapy (CBT) for gastrointestinal symptoms

Enteral or parenteral feeding

Previous gastrointestinal surgery, electrolyte disturbances, kidney dysfunction, renal insufficiency, or iron overload disorders

Estimated Glomerular Filtration Rate (eGFR) < 60

Trial design

Treatments tested in this trial

  • Sensory device
  • Skills Building
  • Health Education
  • Subsensory device

Treatment groups

80 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Spaulding Rehabilitation Hospital

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator